Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-12-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for the combination product spironolactone and hydrochlorothiazide, manufactured by Prasco Laborator…
-
FDA approval · 2022-12-16FDA Approved: FUROSEMIDE — Original Application (Lifestar Pharma LLC)
FDA approved Lifestar Pharma LLC's original application for furosemide, authorizing the generic version of the diuretic for its labeled indi…
-
FDA approval · 2022-10-25FDA Approved: METOLAZONE — Original Application (Aarkish Pharmaceuticals NJ Inc.)
FDA approved the original application for metolazone from Aarkish Pharmaceuticals NJ Inc., granting clearance to manufacture and market a ge…
-
FDA approval · 2022-10-24FDA Approved: METOLAZONE — Original Application (Ingenus Pharmaceuticals LLC)
FDA approves Metolazone via Original Application for a generic version by Ingenus Pharmaceuticals LLC. The approval supports its use for ede…
-
FDA approval · 2022-10-17FDA Approved: FUROSEMIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved Rising Pharma Holdings, Inc.'s original ANDA for furosemide, authorizing a generic version of this diuretic.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-26FDA Approved: CHLORTHALIDONE CHLORTHALIDONE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic chlorthalidone by Alembic Pharmaceuticals Limited.
-
FDA approval · 2022-08-04FDA Approved: CHLORTHALIDONE — Original Application (Lifestar Pharma LLC)
The FDA approved an original application for chlorthalidone from Lifestar Pharma LLC, a generic diuretic indicated for hypertension and edem…
-
FDA approval · 2022-07-26FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for acetazolamide filed by Strides Pharma Science Limited, authorizing an update to the generic prod…
-
FDA approval · 2022-07-06FDA Approved: TRIAMTERENE — Original Application (Biocon Pharma Inc.)
The FDA approved Biocon Pharma Inc.'s original ANDA for Triamterene, granting generic approval to market Triamterene.
-
FDA approval · 2022-05-26FDA Approved: BUMETANIDE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Glenmark Pharmaceuticals USA's Original Application for bumetanide, authorizing the generic diuretic bumetanide for U.S. use.
-
FDA approval · 2022-02-25FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for the generic combination Triamterene and Hydrochlorothiazide from BluePoint Laboratories. The…
-
FDA approval · 2022-02-25FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Triamterene and Hydrochlorothiazide from BluePoint Laboratories, enabling the marketing of t…
-
FDA approval · 2022-02-24FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)
FDA approved the original generic application for chlorthalidone by TAGI Pharma, Inc., allowing market authorization for this thiazide-like …
-
FDA approval · 2022-02-24FDA Approved: CHLORTHALIDONE — Original Application (TAGI Pharma, Inc.)
FDA approved the original application for chlorthalidone from TAGI Pharma, confirming marketing authorization for this generic diuretic.
-
FDA approval · 2022-02-23FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Advagen Pharma Ltd)
Original approval of Triamterene and Hydrochlorothiazide (Advagen Pharma Ltd) under an ANDA.
-
FDA approval · 2022-02-09FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the generic chlorthalidone under an original ANDA from Rising Pharma Holdings, Inc.
-
FDA approval · 2022-01-27FDA Approved: FUROSEMIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved an original generic application for furosemide from Meitheal Pharmaceuticals Inc.
-
FDA approval · 2021-08-19FDA Approved: ACETAZOLAMIDE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's generic acetazolamide under an original (ANDA) application, enabling marketing of a generic formulation of…
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves the original ANDA for Metolazone from Unichem Pharmaceuticals (USA), Inc., establishing its generic status.
-
FDA approval · 2021-03-30FDA Approved: METOLAZONE — Original Application (Method Pharmaceuticals, LLC)
FDA approved METOLAZONE under an original ANDA from Method Pharmaceuticals, LLC (generic approval).
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for spironolactone from Mylan Pharmaceuticals, resulting in changes to the product labeling as p…
-
FDA approval · 2021-02-26FDA Approved: SPIRONOLACTONE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Accord Healthcare's generic spironolactone. This action confirms approval of modifications under…
-
FDA approval · 2021-02-22FDA Approved: ACETAZOLAMIDE — Original Application (TRUPHARMA, LLC)
The FDA approved an original ANDA for Acetazolamide, a generic version manufactured by TRUPHARMA, LLC.
-
FDA approval · 2021-02-19FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide by Prasco Laboratories, authorizing its marketing as …
-
FDA approval · 2021-01-27FDA Approved: FUROSEMIDE — Original Application (Sagent Pharmaceuticals)
FDA approved a new generic version of furosemide from Sagent Pharmaceuticals under an original application, enabling market entry as a loop …